Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

Engineers have developed an automated microfluidic platform that dramatically accelerates the formulation of lipid nanoparticles, the delivery vehicles behind mRNA vaccines and gene therapies.

VanDeMark Chemical is closing a phosgene derivatives plant in Lockport, New York, by May 25, according to a March 4 notice, which says 69 workers will be out of a job. VanDeMark and the Hungarian ...

Researchers developed an automated microfluidic platform that produces up to 1,000 lipid nanoparticle formulations per hour. The system generates large datasets that could help AI predict optimal ...

Researchers developed a DNA barcoding assay to measure nanoparticle cargo escape in living organisms, enabling a new class of lipid nanoparticles for more efficient gene editing.

Researchers in Brazil have reported that ferroin, an iron complex delivered by lipid nanoparticles, eliminates detectable Mycobacterium tuberculosis from mouse lungs after 30 days, suggesting a ...

An employee from a private organization undergoes the First Patient Encounter during the PhilHealth YAKAP Caravan. The FPE is an initial, mandatory in-person consultation that establishes a baseline ...

Here's why it is a major problem that needs attention and how you can do the purity check at home.

Tiny, sun-powered organisms found in freshwater pools could soon fuel Hawaiʻi's sustainable future. Researchers at the University of Hawaiʻi at Mānoa are charting a path to transform microalgae into a ...

To our knowledge, this analysis is the largest EHR-based study for identifying drug repurposing candidates for ALS. We identified several drugs that warrant further assessment as therapeutic options ...

UMN Hormel Institute study: grass-fed regenerative organic beef improved cholesterol, triglycerides and inflammation markers vs conventional, earning national research award finalist status.

Announcing GeneDx's new genetic testing program with Zevra Therapeutics to support patients with suspected Niemann–Pick disease type C (NPC).